Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Introducing UNICORN Signals

Powered By EquityPandit
4.5 Google Ratings

Glenmark Pharmaceuticals Ltd

NSE :GLENMARK   BSE :532296  Sector : Pharmaceuticals
Buy, Sell or Hold GLENMARK? Ask The Analyst
Explore on Dhan
Gift Nifty Candle Stick Chart Buy X Sell
Check Gift Nifty (SGX Nifty) Live Price to predict the market.

BSE
Apr 22, 00:00

1390.10

21.10 (1.54%)

prev close

1369.00

OPEN PRICE

1378.55

volume

12950

Today's low / high

1361.00 / 1407.80

52 WK low / high

985.60 / 1830.05

bid price (qty)

0 (0)

offer price (qty)

0 (0)

NSE
Apr 22, 00:00

1390.80

22.00 (1.61%)

prev close

1368.80

open price

1374.50

volume

844434

Today's' low / high

1359.60 / 1408.00

52 WK low / high

985.20 / 1830.95

bid price (qty)

1390.80 (14)

offer price (qty)

0 (0)

22 Apr
1390.80
(1.61%)
21 Apr
1368.80
(1.97%)
17 Apr
1342.40
(-1.06%)
16 Apr
1356.80
(-1.46%)
15 Apr
1376.90
(-0.09%)
11 Apr
1378.10
(0.13%)
09 Apr
1376.30
(-4.48%)
08 Apr
1440.80
(-0.10%)
07 Apr
1442.20
(-3.84%)
04 Apr
1499.85
(-2.94%)
03 Apr
1545.25
(1.97%)
02 Apr
1515.45
(0.41%)
01 Apr
1509.20
(-2.07%)
28 Mar
1541.05
(1.39%)
27 Mar
1519.85
(3.97%)
26 Mar
1461.80
(-1.28%)
25 Mar
1480.75
(-0.80%)
24 Mar
1492.65
(-1.46%)
21 Mar
1514.75
(2.43%)
20 Mar
1478.80
(-0.53%)
19 Mar
1486.70
(2.08%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Bearish
Medium Term Investors

Neutral
Long Term Investors

Very Bearish

Moving Averages

5 DMA
Bullish

1366.62

10 DMA
Bearish

1396.69

20 DMA
Bearish

1451.13

50 DMA
Bearish

1419.04

100 DMA
Bearish

1472.68

200 DMA
Bearish

1533.62


Intraday Support and Resistance
(Based on Pivot Points) NSE : 1390.80 | BSE : 1390.10

Updated On Apr 22, 2025 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1461.06 1434.53 1404.11 - -
R2 1434.53 1416.04 1399.67 1435.7 -
R1 1412.66 1404.62 1395.24 1415 1423.6
P 1386.13 1386.13 1386.13 1387.3 1391.6
S1 1364.26 1367.64 1386.36 1366.6 1375.2
S2 1337.73 1356.22 1381.93 1338.9 -
S3 1315.86 1337.73 1377.49 - -

Key Metrics

EPS

81.65

P/E

16.77

P/B

1.61

Dividend Yield

0.18%

Market Cap

38,626 Cr.

Face Value

1

Book Value

861.66

ROE

-50.87%

EBITDA Growth

630.36 Cr.

Debt/Equity

0.34

Shareholding Pattern

  46.65% Total Promoter Holding
12.86% Mutual Fund Holdings
23.16% FIIs
15.56% Non Institution
0.43% Insurance Companies
0% Custodians
1.34% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Glenmark Pharmaceuticals Ltd Quaterly Results


Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
INCOME2670.88 3860.49 3275.68 3473.21 3418.68
PROFIT-393.41 -2285.2 340.27 354.21 347.96
EPS-12.45 -43.17 12.06 12.55 12.33

Glenmark Pharmaceuticals Ltd Quaterly Results


Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
INCOME1623.91 8081.41 2385.19 2719.18 2380.47
PROFIT4.87 841.36 453.73 595.06 413.8
EPS-0.72 163.5 16.08 21.09 14.66

Profit & Loss (Figures in Rs. Crores)


Glenmark Pharmaceuticals Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 6943.01 7721.83 9576.39 9032.11 10299.46 10705.37 11227.94 12482.71 12579.76 13246.04
PROFIT 263.52 743.05 1155.03 805.34 818.68 755.72 941.32 1107.67 609.68 -4473.72
EPS 7.3 26.33 39.29 28.49 32.78 27.5 34.38 35.21 13.37 -50.8

Glenmark Pharmaceuticals Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 5358.49 6306 8220.99 5709.21 6787.67 7289.2 8032.82 9202.67 9237.97 14232.55
PROFIT 1139.79 1484.9 2322 1016.26 1344.95 1340.12 1589.58 1643.77 1578.33 1425.03
EPS 36.72 52.6 75.86 35.95 57.49 48 58.46 70.8 42.84 183.11

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 28.2228.2228.2228.2228.2228.2228.2228.2228.2227.13
Reserves Total 7,819.719,445.719,058.437,036.416,042.295,576.975,135.264,464.313,601.421,756.36
Total Shareholders Funds7,847.939,473.939,086.657,064.636,070.515,605.195,163.484,492.533,629.641,783.49
Minority Interest-0.38365.34351.47-0.35-0.39-0.38-0.37-0.42-0.3-0.19
Secured Loans 000006.1119.742.5915.5336.69
Unsecured Loans 1,230.934,607.883,962.024,985.724,868.634,442.564,619.644,721.063,972.583,763.24
Total Debt1,230.934,607.883,962.024,985.724,868.634,448.674,639.384,723.653,988.113,799.93
Other Liabilities540.52397.59152.5196.68429.2789.142.632.7476.99121.92
Total Liabilities9,61914,844.7413,552.6412,246.6811,368.0210,142.629,805.099,248.57,694.445,705.15
APPLICATION OF FUNDS :
Gross Block 9,619.6410,359.5910,213.478,731.588,269.836,527.275,367.954,769.924,300.543,495.47
Less: Accumulated Depreciation5,409.484,937.834,326.233,602.733,241.282,857.012,338.42,014.831,706.991,480.09
Net Block4,210.165,421.765,887.245,128.855,028.553,670.263,029.552,755.092,593.552,015.38
Capital Work in Progress661.881,189.641,009.871,381.671,221.891,398.941,121.87708.11542.8477.13
Investments 789.6644.5749.6224.6324.5929.6614.6615.6917.217.12
Inventories 2,513.052,373.622,499.832,276.832,135.622,252.072,030.592,139.051,567.761,269.04
Sundry Debtors 1,858.413,665.173,101.142,572.062,408.962,194.592,331.812,404.322,492.652,511.77
Cash and Bank Balance1,659.461,160.31,411.521,139.161,111.24937.771,234.691,057.66857.12775.88
Loans and Advances 1,397.173,526.441,269.871,371.541,147.781,312.41,391.611,273.61986.77774.38
Total Current Assets7,428.0810,725.538,282.357,359.586,803.616,696.836,988.696,874.645,904.35,331.07
Current Liabilities 3,807.273,935.932,914.642,763.72,744.432,662.082,357.822,252.412,364.422,334.38
Provisions 932.08590.51584.5564.45555.91484.11432.46262.95134.03216.78
Total Current Liabilities & Provisions4,739.354,526.443,499.143,328.163,300.343,146.182,790.282,515.362,498.442,551.16
Net Current Assets2,688.746,199.094,783.214,031.423,503.273,550.654,198.414,359.273,405.862,779.91
Deferred Tax Assets1,049.721,805.911,969.551,852.181,770.851,761.631,728.581,553.351,274.96169.73
Deferred Tax Liability0.280.51314.93346.26331.59378.68408.32242.08210.07222.52
Net Deferred Tax1,049.441,805.41,654.621,505.921,439.261,382.951,320.261,311.271,064.89-52.79
Other Assets219.11184.27168.08174.18150.45110.16120.3499.0670.15468.42
Total Assets9,618.9914,844.7313,552.6512,246.6711,368.0110,142.619,805.099,248.497,694.445,705.16
Contingent Liabilities1,063.3336.69361.31384.2271.2173.5147.136.8836.89129.37
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 28.2228.2228.2228.2228.2228.2228.2228.2228.2227.13
Reserves Total 22,942.417,849.2516,710.3714,781.2913,198.0511,913.8710,363.229,408.47,337.754,924.92
Total Shareholders Funds22,970.6217,877.4716,738.5914,809.5113,226.2711,942.0910,391.449,436.627,365.974,952.05
Secured Loans 000006.1119.742.5915.5336.69
Unsecured Loans 707.293,221.223,737.73,703.993,573.763,128.372,961.332,773.94771.89373.41
Total Debt707.293,221.223,737.73,703.993,573.763,134.482,981.072,776.53787.42410.1
Other Liabilities131.94372.58121.32136.61205.6588.512.62.414.7121.92
Total Liabilities23,809.8521,471.2720,597.6118,650.1117,005.6815,165.0813,375.1112,215.568,158.095,484.07
APPLICATION OF FUNDS :
Gross Block 3,392.753,183.653,026.282,848.562,595.062,260.12,581.752,368.532,107.041,801.98
Less : Accumulated Depreciation 1,636.51,437.71,273.951,126.07983.11846.62882.63772.16669.04571.3
Net Block 1,756.251,745.951,752.331,722.491,611.951,413.481,699.121,596.371,4381,230.68
Capital Work in Progress197.67172.34109.04131.4200.01286.2419.68270.66276.06294.19
Investments 12,964.7910,332.718,559.396,989.954,713.933,268.753,212.681,866.71,858.431,659.52
Inventories 1,142.691,090.21951.66762.39837.5911.211,111.181,145.06968736.63
Sundry Debtors 2,484.472,505.662,678.322,488.751,835.242,087.133,828.913,879.43,057.662,440.83
Cash and Bank Balance129.1593.7929.6315.7988.26256.48177.38252.1874.2448.55
Loans and Advances 925.17696.82743.311,642.21,662.891,886.33757.78674.19528.03371.94
Total Current Assets4,681.484,386.484,402.934,909.124,423.895,141.155,875.255,950.834,627.933,597.95
Current Liabilities 3,249.792,952.142,168.391,834.311,827.481,855.861,796.561,727.021,867.561,882.99
Provisions 354.74162.52148.49133.11118.45121.7593.257.9787.37151.38
Total Current Liabilities & Provisions3,604.543,114.662,316.881,967.411,945.921,977.621,889.761,784.981,954.932,034.37
Net Current Assets1,076.941,271.822,086.052,941.712,477.973,163.543,985.494,165.852,672.991,563.58
Deferred Tax Assets475.611,160.251,137.471,118.721,081.341,063.231,056.45820.62589.4124.84
Deferred Tax Liability309.77213.5214.2265.43276.6351.1395.83226.56188.25157.23
Net Deferred Tax165.84946.75923.27853.29804.74712.13660.62594.06401.16-132.39
Other Assets7,648.377,001.77,167.546,011.277,197.086,320.983,397.523,721.921,511.43868.49
Total Assets23,809.8521,471.2620,597.6218,650.1117,005.6815,165.0813,375.1112,215.568,158.085,484.07
Contingent Liabilities2,658.493,443.33,325.063,730.174,430.593,680.944,549.63,720.764,594.015,326.65

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...569.19
Depreciation630.81
Interest (Net)500.14
P/L on Sales of Assets-0.83
P/L on Sales of Invest-7.05
Prov. and W/O (Net)68.38
P/L in Forex-342.59
Total Adjustments (PBT and Ext...1,009.81
Operating Profit before Workin...1,579
Trade and 0ther Receivables969.51
Inventories-513.86
Trade Payables-734.41
Total Adjustments (OP before W...-796.95
Cash Generated from/(used in) ...782.05
Direct Taxes Paid-1,047.49
Total Adjustments(Cash Generat...-1,047.49
Cash Flow before Extraordinary...-265.44
Net Cash from Operating Activi...-265.44
Purchased of Fixed Assets-898.38
Sale of Fixed Assets2.08
Sale of Investments7.05
Interest Received17.16
Cancellation of Investment in ...5,449.61
Net Cash used in Investing Act...4,386.82
Proceeds from Issue of shares ...1.2
Proceed from Short Tem Borrowi...481.12
Of the Long Tem Borrowings-3,649.49
Of Financial Liabilities-104.43
Dividend Paid-117.75
Interest Paid-516.78
Net Cash used in Financing Act...-3,906.13
Net Profit before Tax and Extr...7,000.75
Depreciation202.16
Interest (Net)103.58
Dividend Received228.39
P/L on Sales of Assets0.25
P/L on Sales of Invest-7.05
Prov. and W/O (Net)33.39
P/L in Forex-173.41
Total Adjustments (PBT and Ext...-5,884.79
Operating Profit before Workin...1,115.96
Trade and 0ther Receivables-63.2
Inventories-147.52
Trade Payables-272.03
Total Adjustments (OP before W...-740.31
Cash Generated from/(used in) ...375.65
Direct Taxes Paid-871.1
Total Adjustments(Cash Generat...-871.1
Cash Flow before Extraordinary...-495.45
Net Cash from Operating Activi...-495.45
Purchased of Fixed Assets-195.11
Sale of Fixed Assets0.5
Sale of Investments7.05
Interest Received278.45
Invest.In Subsidiaires-9.05
Loans to Subsidiaires-2,562.51
Cancellation of Investment in ...5,449.61
Net Cash used in Investing Act...3,197.17
Proceeds from Issue of shares ...1.2
Proceed from Short Tem Borrowi...150
Of the Long Tem Borrowings-2,449.18
Of Financial Liabilities-35.63
Dividend Paid-70.45
Interest Paid-262.39
Net Cash used in Financing Act...-2,666.45

Company Details

Registered Office
AddressB/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road
CityMumbai
StateMaharashtra
Pin Code400026
Tel. No.91-22-40189999
Fax. No.91-22-40189986
Emailcomplianceofficer@glenmarkpharma.com
Internethttp://www.glenmarkpharma.com
Registrars
AddressB/2 Mahalaxmi Chambers
CityMumbai
StateMaharashtra
Pin Code400026
Tel. No.91-22-40189999
Fax. No.91-22-40189986
Emailcomplianceofficer@glenmarkpharma.com
Internethttp://www.glenmarkpharma.com
Management
Name Designation
Glenn SaldanhaChairman & Managing Director
Cheryl PintoExecutive Director (Corporate)
V S ManiExecutive Director & Group CFO
B E SaldanhaNon Executive Director
Rajesh Desai.Independent Non Exe. Director
Sona Saira RamasastryIndependent Non Exe. Director
Dipankar BhattacharjeeIndependent Non Exe. Director
V R IyerIndependent Non Exe. Director
Pradeep Kumar SinhaAdditional Director